Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cancer genetic counselling for hereditary breast cancer in the era of precision oncology.

Cancer treatment reviews - 1 Apr 2024

Pensabene M, Calabrese A, von Arx C, Caputo R, De Laurentiis M

Abstract excerpt

A relevant percentage of breast cancers (BCs) are tied to pathogenetic (P)/likely pathogenetic (LP) variants in predisposing genes. The knowledge of P/LP variants is an essential element in the management of BC patients since the first diagnosis because it influences surgery and subsequent oncological treatments and follow-up. Moreover, patients with metastatic BCs can benefit from personalized treatment if...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Counseling

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Mutation

Share to Precision Medicine

Source

Identifiers

PMID: 38452709
DOI: 10.1016/j.ctrv.2024.102702

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cancer genetic counselling for hereditary breast cancer in the era of precision oncology.PMID 38452709Read ↗

Prevention, diagnosis and clinical management of hereditary breast cancer beyond BRCA1/2 genes.Semantic proximity Read ↗

Multigenic panels in breast cancer: Clinical utility and management of patients with pathogenic variants other than BRCA1/2.Semantic proximity Read ↗

Hereditary breast cancer: an update on risk assessment and genetic testing in 2015.Semantic proximity Read ↗

Updates in hereditary breast cancer genetic testing and practical high risk breast management in gene carriers.Semantic proximity Read ↗

Hereditary Breast Cancer: Comprehensive Risk Assessment and Prevention StrategiesSemantic proximity Read ↗

Hereditary breast cancer: from bench to bedside.Semantic proximity Read ↗

Breast cancer multigene germline panel testing in mainstream oncology based on clinical-public health utility (cancer mortality benefit): ESMO Precision Oncology Working Group recommendationsSemantic proximity Read ↗

Utility of Expedited Hereditary Cancer Testing in the Surgical Management of Patients with a New Breast Cancer Diagnosis.Semantic proximity Read ↗

Consensus Guidelines on Genetic` Testing for Hereditary Breast Cancer from the American Society of Breast SurgeonsSemantic proximity Read ↗

Breast cancer germline multigene panel testing in mainstream oncology based on clinical–public health utility: ESMO Precision Oncology Working Group recommendationsSemantic proximity Read ↗

Hereditary breast cancer syndromes and genetic testingSemantic proximity Read ↗

Assessing, Counseling, and Treating Patients at High Risk for Breast Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.